 |
|
Changes in High-Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial
Eun-Jae Lee, Sun U. Kwon, Jong-Ho Park, Yong-Jae Kim, Keun-Sik Hong, Sungwook Yu, Yang-Ha Hwang, Ji Sung Lee, Juneyoung Lee, Joung-Ho Rha, Sung Hyuk Heo, Sung Hwan Ahn, Woo-Keun Seo, Jong-Moo Park, Ju-Hun Lee, Jee-Hyun Kwon, Sung-Il Sohn, Jin-Man Jung, Hahn Young Kim, Eung-Gyu Kim, Sung Hun Kim, Jae-Kwan Cha, Man-Seok Park, Hyo Suk Nam, Dong-Wha Kang,
J Stroke. 2020;22(1):108-118. Published online 2020 Jan 31 DOI: https://doi.org/10.5853/jos.2019.02551
|
|
Citations to this article as recorded by
 Cardiovascular risk assessment of newborns in Nigeria using the atherogenic index of plasma and its associations with gestational age and birth weight: a cross-sectional hospital-based study
Obinna Victory Obaji, Uche Charles Adizua, Ndubuisi Kennedy Chukwudi, Daberechi Kenneth Adiele, Justus Uchenna Onu
Cardiovascular Prevention and Pharmacotherapy.2024; 6(2): 65. CrossRef Probucol will become a new model for treating cerebral infarction with a high risk of hemorrhage: A narrative review
Liguo Lang, Jianying Zhang, Dongju Zheng, Huanmin Gao
Brain Circulation.2023; 9(4): 222. CrossRef PREDICTORS OF ATHEROSCLEROTIC PLAQUE DESTABILIZATION AND THE POSSIBILITY OF ITS CORRECTION
V. Lyzogub, T. Motsak , O. Savchuk, O. Kupchynska, L. Kuzmenko, V-S. Galych , D. Novik
Medical Science of Ukraine (MSU).2023; 19(4): 55. CrossRef Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT
Hidenori Arai, Hideaki Bujo, Daisaku Masuda, Toshiyuki Ishibashi, Satoshi Nakagawa, Kenichiro Tanabe, Tatsuo Kagimura, Hyun-Jae Kang, Moo Hyun Kim, Jidong Sung, Sang-Hyun Kim, Cheol-Ho Kim, Jeong Euy Park, Junbo Ge, Byung-Hee Oh, Toru Kita, Yasushi Saito,
Journal of Atherosclerosis and Thrombosis.2022; 29(6): 850. CrossRef
|